Dose and timing requirements for immunogenicity of viral poultry vaccine antigen: Investigations of emulsion-based depot function

Avian Pathology

Volumn 36, Issue 5, 2007, Pages 361-365

  Jansen, Theo ^a   Hofmans, Marij P M ^a   Theelen, Marc J G ^a   Manders, Frans G A ^a   Schijns, Virgil E J C ^a  

^a INTERVET INTERNATIONAL BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN; VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; ANTIBODY PRODUCTION; ARTICLE; BIRD DISEASE; CHICKEN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED RELEASE FORMULATION; DOSE RESPONSE; DRUG ADMINISTRATION; EMULSION; FEMALE; GERMFREE ANIMAL; IMMUNOLOGY; INFECTIOUS BURSAL DISEASE VIRUS; VIRUS INFECTION;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, VIRAL; BIRNAVIRIDAE INFECTIONS; CHICKENS; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG ADMINISTRATION SCHEDULE; EMULSIONS; FEMALE; INFECTIOUS BURSAL DISEASE VIRUS; POULTRY DISEASES; SPECIFIC PATHOGEN-FREE ORGANISMS; VIRAL VACCINES;

ANIMALIA; GALLUS GALLUS; INFECTIOUS BURSAL DISEASE VIRUS;

EID: 34848824641     PISSN: 03079457     EISSN: 14653338     Source Type: Journal    
DOI: 10.1080/03079450701567395     Document Type: Article

References (18)

1. Aucouturier, J., Dupuis, L. & Ganne, V. (2001). Adjuvants designed for veterinary and human vaccines. Vaccine, 19, 2666-2672.
2. Bachmann, M.F., Rohrer, U.H., Kundig, T.M., Burki, K., Hengartner, H. & Zinkernagel, R.M. (1993). The influence of antigen organization on B cell responsiveness. Science, 262, 1448-1451.
3. De Wit, M.C., Horzinek, M.C., Haagmans, B.L. & Schijns, V.E.J.C. (2004). Host-dependent type 1 cytokine responses driven by inactivated viruses may fail to default in the absence of IL-12 or IFN-alpha/beta. Journal of General Virology, 85, 795-803.
4. Dupuis, M., Murphy, T.J., Higgins, D., Ugozzoli, M., van Nest, G., Ott, G. & McDonald, D.M. (1998). Dendritic cells internalize vaccine adjuvant after intramuscular injection. Cellular Immunology, 186, 18-27.
5. Flarend, R.E., Hem, S.L., White, J.L., Elmore, D., Suckow, M.A., Rudy, A.C. & Dandashli, E.A. (1997). In vivo absorption of aluminium-containing vaccine adjuvants using 26Al. Vaccine, 15, 1314-1318.
6. Freund, J. (1951). The effect of paraffin oil and mycobacteria on antibody formation and sensitization. American Journal of Clinical Pathology, 21, 645-656.
7. Gavin, A.L., Hoebe, K., Duong, B., Tkayuki, O., Martin, Ch., Beutler, B. & Nemanzee, D. (2006). Adjuvant-induced antibody responses in the absence of Toll-like receptor signalling. Science, 314, 1936-1938.
8. Herbert, W.J. (1966). Antigenicity of soluble protein in the presence of high levels antibody: a possible mode of action of the antigen adjuvants. Nature, 210, 747-748.
9. Herbert, W.J. (1968). The mode of action of mineral-oil emulsion adjuvants on antibody production in mice. Immunology, 14, 301-318.
10. Itano, A.A., McSorley, S.J., Reinhardt, R.L., Ehst, B.D., Ingulli, E. & Jenkins, M.K. (2003). Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity, 19, 47-57.
11. Jansen, T., Hofmans, M.P.M., Theelen, M. & Schijns, V.E.J.C. (2005). Structure-activity relations of water-in-oil vaccine formulations and induced antigen-specific antibody responses. Vaccine, 23, 1053-1060.
12. Jansen, T., Hofmans, M.P.M., Theelen, M., Manders, F. & Schijns, V.E.J.C. (2006). Structure-and oil type-based efficacy of emulsion adjuvants. Vaccine, 24, 5400-5405.
13. Jegerlehner, A., Tissot, A., Lechner, F., Sebbel, P., Erdmann, I., Kündig, T., Bächi, T., Storni, T., Jennings, G., Pumpens, P., Renner, W.A. & Bachmann, M.F. (2002). A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses. Vaccine, 20, 3104-3112.
14. Lascelles, A.K., Eagleson, G., Beh, K.J. & Watson, D.L. (1989). Significance of Freund's adjuvant/antigen injection granuloma in the maintenance of serum antibody response. Veterinary Immunology and Immunopathology, 22, 15-27.
15. Le, Moignic & Pinoy (1916). Les vaccins en emulsion dans les corps gras ou "lipo-vaccins". Comptes Rendus de la societe de Biologie, 79, 201-203.
16. Rijke, E.O., Cornelius, L. & Schrier, C. (1995). Experiences with a tocopherol-based adjuvant in chickens. In T.F. Davison, N. Bumstead & P. Kaiser (Eds.), Advances in Avian Immunology Research (pp. 265-271). Carfax Publishing Company, Abingdon.
17. Schijns, V.E.J.C. (2000). Immunological concepts of vaccine adjuvant activity. Current Opinion in Immunology, 12, 456-463.
18. Whitehouse, M.W., Orr, K.J., Beck, F.W.J. & Pearson, C.M. (1974). Freund's adjuvants: relationship of arthritogenicity and adjuvanticity in rats to vehicle composition. Immunology, 27, 311-330.